[Antiviral agents for influenza].
Mitamura
Keiko
K
Department of Pediatrics, Eiju General Hospital.
D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D024882:Drug Resistance, Viral; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D014763:Viral Matrix Proteins / Q000037:antagonists & inhibitors; D053243:Zanamivir / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000086082:Viroporin Proteins
D000547:Amantadine; D000998:Antiviral Agents; D009439:Neuraminidase; D053139:Oseltamivir; D014763:Viral Matrix Proteins; D053243:Zanamivir; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins